ReNerve Limited (ASX:RNV)
Australia · Delayed Price · Currency is AUD 0.0800
-0.0050 (-5.88%)
At close: Aug 5, 2026
ReNerve Market Cap
ReNerve has a market cap or net worth of 13.78 million as of August 5, 2026. Its market cap has decreased by -2.82% in one year.
Market Cap
13.78M
Enterprise Value
9.76M
Revenue
333.21K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
ChartMarket Cap Chart
Since November 26, 2024, ReNerve's market cap has decreased from 26.95M to 13.78M, a decrease of -48.85%. That is a compound annual growth rate of -32.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 13.78M | -16.69% |
| Dec 31, 2025 | 16.55M | -33.34% |
| Dec 31, 2024 | 24.82M | -7.89% |
| Nov 26, 2024 | 26.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeuroScientific Biopharmaceuticals | 23.38M |
| Neurotech International | 22.40M |
| Proteomics International Laboratories | 22.30M |
| Patrys | 22.00M |
| EZZ Life Science Holdings | 21.89M |
| Argenica Therapeutics | 19.91M |
| Ceryvyn Therapeutics | 16.42M |
| Immuron | 11.76M |